Instrument Inactif

Autres langues Algeta ASA

Actions

ALGETA

NO0010239437

Recherche biotechnologique et médicale

Autres langues

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma
06/05/14	Actavis : M&A frenzy in healthcare sector
24/03/14	Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo
24/02/14	Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta
19/12/13	Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid
19/12/13	Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid
26/11/13	OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
26/11/13	OTSUKA CORPORATION : Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
26/11/13	Bayer AG : Bayer says does not want to provide details on Algeta offer
18/11/13	Algeta ASA : Algeta to host Capital Markets Days
08/11/13	Algeta ASA : Algeta's Financial Calendar 2014
08/11/13	Algeta ASA : CORRECTION: Algeta ASA : Algeta Results for the Third Quarter 2013
05/11/13	Algeta ASA : Algeta to Participate in Upcoming Investor Conferences
28/10/13	Algeta ASA : Algeta Schedules Third Quarter 2013 Results Presentation, Webcast and Conference Call
12/09/13	Algeta ASA : New data and analyses from the phase III ALSYMPCA trial of radium Ra 223 dichloride to be presented at the European Cancer Congress (ECCO-ESMO-ESTRO) 2013
28/08/13	Algeta ASA : Algeta results for the First Half and Second Quarter 2013
19/08/13	Algeta ASA : Algeta schedules first half and second quarter 2013 results presentation, webcast and conference call
19/08/13	Algeta ASA : Algeta Appoints Dr Andreas Menrad as Chief Scientific Officer
12/08/13	Algeta ASA : Algeta to Participate in Upcoming Investor Conferences
20/06/13	Algeta ASA : Algeta celebrates the official opening of its commercial production facility for Xofigo® (radium Ra 223 dichloride) at the Institute for Energy Technology (IFE) in Norway
11/06/13	Algeta ASA : Algeta to evaluate novel Targeted Thorium Conjugate (TTC) based on Avipep's Avibody platform
30/05/13	Algeta ASA : Algeta announces first sale of Xofigo® (radium Ra 223 dichloride) in the United States
16/05/13	Algeta ASA : New data and analyses from clinical trials of Xofigo® (radium-223 dichloride) to be presented at ASCO
15/05/13	Algeta ASA : Algeta announces that Xofigo® (radium-223 dichloride) has been approved by the US FDA
15/05/13	Algeta ASA : Algeta results for the first quarter 2013